Morris Goodman, Co-Founder and President Emeritus of Pharmascience Inc., Awarded Honorary Doctorate by INRS

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Morris Goodman, Co-Founder and President Emeritus of Pharmascience Inc., Awarded Honorary Doctorate by INRS

Canada NewsWire

MONTREAL, May 14, 2024 /CNW/ - Pharmascience Inc. is proud to announce that Morris Goodman, Co-Founder and President Emeritus, has been awarded an honorary doctorate by the National Institute of Scientific Research (INRS) at its annual graduation ceremony. This highest academic honor recognizes Mr. Goodman's involvement and invaluable dedication to the healthcare sector throughout his distinguished career, as well as his generosity towards health research.

It is a great honor for Mr. Goodman to join the privileged ranks of those who have received this exceptional tribute for their contributions to science and society. Recognized as a pioneering influence in the Canadian generic pharmaceutical industry, he has played a crucial role in transforming healthcare by making medications more accessible and affordable, not only in Quebec but also internationally. His vision and philanthropic commitment have had a significant impact on all Canadians throughout his career.

The entire Pharmascience family extends its heartfelt congratulations to Mr. Goodman for his most inspiring career!

About Pharmascience Inc.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,600 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries. Ranked 52nd among Canada's top 100 Research and Development (R&D) investors in 2023, with $40-50 million invested each year, Pharmascience Inc. is among the largest drug manufacturers in Canada.

Pharmascience Inc. has strong values based on the importance of investing in employees and young people. Through various programs and initiatives, the company is dedicated to supporting their personal development and life. In 2024, the company was awarded Great Place to Work certification for the third consecutive year, and also made the Top 50 best places to work in Canada by Great Place to Work Canada for the category of companies with over 1,000 employees.

SOURCE Pharmascience Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2024/14/c4658.html

Copyright CNW Group 2024

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).